CMPX Compass Therapeutics, Inc. - Common Stock
$1,82
Cena · Maj 20, 2026
Dane fundamentalne na dzień Maj 5, 2026
Zakres 52 tyg.
$2–$7
4% of range
Ocena Analityków
BUY
21 analysts
Cena Docelowa
$11
+481% upside
P/E (TTM)
—
ROE
-45.9%
Marża Zysku Netto
—
CMPX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$1.82
Kapitalizacja Rynkowa
$958M
P/E (TTM)
—
EPS (TTM)
—
Przychody (TTM)
$0
Stopa dywidendy
—
ROE
-45.9%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $7
CMPX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$0
2023-12-31
→
2025-12-31
EPS
—
Wolny przepływ pieniężny
$-49M
2020-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
CMPX
Mediana porównawcza
P/B
4.9
2.9
Price / FCF (Cena / FCF)
-19.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
CMPX
Mediana porównawcza
ROA
-36.9%
-46.8%
ROE
-45.9%
-46.0%
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
CMPX
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
15.0
8.3
Quick Ratio (Wskaźnik Szybkości)
15.0
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
CMPX
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
CMPX
Mediana porównawcza
CMPX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
21 analityków
- Mocne kupno 8 38,1%
- Kup 11 52,4%
- Trzymaj 2 9,5%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
12 analityków · 2026-05-14
Mediana
$7.50
Średnia
$10.58
← Poniżej wszystkich celów
$1.82
Niski
$4.00
Wysoki
$30.00
Średni cel
$7.50
+312,1%
Średnia cel
$10.58
+481,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $-0.10 | $-0.10 | 0.00% |
| 31 grudnia 2025 | $-0.09 | $-0.09 | 0.00% |
| 30 września 2025 | $-0.08 | $-0.14 | 0.06% |
| 30 czerwca 2025 | $-0.14 | $-0.12 | -0.02% |
| 31 marca 2025 | $-0.12 | $-0.11 | -0.01% |
Porównanie jednostek Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CMPX | $958M | — | — | — | -45.9% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | — |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | — |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
| IMRX | — | -5.2 | — | — | -45.3% | — |
| RCKT | — | — | — | — | — | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| PALI | $375M | -7.8 | — | — | -25.4% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $850.0K | $0 | |
| R&D Expense | $56M | $42M | $38M | |
| SG&A Expense | $17M | $15M | $12M | |
| Operating Expenses | $73M | $57M | $50M | |
| Operating Income | $-73M | $-57M | $-50M | |
| Interest Income | $6M | $7M | $8M | |
| Other Non-op | $6M | $7M | $8M | |
| Pretax Income | · | · | $-42M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-66M | $-49M | $-42M | |
| EPS (Basic) | $-0.42 | $-0.36 | $-0.33 | |
| Shares (Basic) | 157,695,000 | 137,384,000 | 127,027,000 | |
| Shares (Diluted) | · | 137,400,000 | · | |
| EBITDA | $-73M | $-57M | $-50M |
Bilans 20
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $31M | $43M | $24M | |
| Short-term Investments | $178M | $83M | $128M | |
| Prepaid Expense | $913.0K | $6M | $1M | |
| Current Assets | $210M | $133M | $154M | |
| PP&E (Net) | $102.0K | $353.0K | $898.0K | |
| PP&E (Gross) | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $6M | $6M | |
| Other Non-current Assets | · | $568.0K | $320.0K | |
| Total Assets | $220M | $140M | $157M | |
| Accounts Payable | $2M | $2M | $4M | |
| Accrued Liabilities | $11M | $6M | $3M | |
| Current Liabilities | $14M | $9M | $8M | |
| Capital Leases | $9M | $6M | $536.0K | |
| Total Liabilities | $23M | $15M | $8M | |
| Common Stock | $18.0K | $14.0K | $13.0K | |
| Retained Earnings | $-431M | $-365M | $-315M | |
| AOCI | $280.0K | $210.0K | $37.0K | |
| Stockholders' Equity | $197M | $125M | $149M | |
| Liabilities + Equity | $220M | $140M | $157M | |
| Shares Outstanding | 178,324,000 | 137,820,000 | 127,668,000 |
Przepływy pieniężne 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $276.0K | $589.0K | $699.0K | |
| Stock-based Comp | $8M | $9M | $6M | |
| Operating Cash Flow | $-49M | $-45M | $-41M | |
| CapEx | $25.0K | $44.0K | $30.0K | |
| Investing Cash Flow | $-93M | $47M | $27M | |
| Stock Issued | $138M | $18M | $3M | |
| Net Stock Activity | $138M | $18M | $3M | |
| Financing Cash Flow | $130M | $17M | $3M | |
| Net Change in Cash | $-13M | $19M | $-11M | |
| Free Cash Flow | $-49M | $-45M | $-41M |
Rentowność 6
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -6661.8% | · | |
| Net Margin | · | -5808.8% | · | |
| EBITDA Margin | · | -6661.8% | · | |
| ROA | -36.9% | -33.2% | -23.8% | |
| ROE | -45.9% | -37.5% | -27.5% | |
| ROIC | · | · | -33.9% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 15.0 | 15.0 | 19.7 | |
| Quick Ratio | 15.0 | 14.3 | 19.5 |
Efektywność 1
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Wycena (TTM) 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $850.0K | $0 | |
| Net Income TTM | $-66M | $-49M | $-42M | |
| Market Cap | $958M | $200M | $199M | |
| P/S | · | 235.1 | · | |
| P/B | 4.9 | 1.6 | 1.3 | |
| P / Tangible Book | 4.9 | 1.6 | 1.3 | |
| P / Cash Flow | -19.5 | -4.5 | -4.9 | |
| P / FCF | -19.5 | -4.5 | -4.9 |
Rachunek zysków i strat 14
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $0 | $0 | $0 | · | $0 | $0 | $850.0K | · | $0 | $0 | $0 | |
| R&D Expense | $13M | $14M | $13M | $16M | $13M | $13M | $9M | $11M | $10M | · | · | · | |
| SG&A Expense | $7M | $4M | $3M | $5M | $5M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $20M | $18M | $16M | $21M | $18M | $17M | $12M | $16M | $13M | $15M | $12M | $13M | |
| Operating Income | $-20M | $-18M | $-16M | $-21M | $-18M | $-17M | $-12M | $-15M | $-13M | $-15M | $-12M | $-13M | |
| Interest Income | · | · | · | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Pretax Income | · | · | · | · | $-17M | · | · | $-13M | $-11M | · | $-10M | $-11M | |
| Income Tax | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-18M | $-16M | $-14M | $-20M | $-17M | $-15M | $-10M | $-13M | $-11M | $-13M | $-10M | $-11M | |
| EPS (Basic) | $-0.10 | $-0.08 | $-0.08 | $-0.14 | $-0.12 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.09 | |
| Shares (Basic) | 186,400,000 | -287,605,000 | 168,782,000 | 138,282,000 | 138,236,000 | -274,402,000 | 137,589,000 | 137,589,000 | 136,608,000 | -253,501,000 | 127,424,000 | 126,729,000 | |
| Shares (Diluted) | · | · | · | · | 138,200,000 | 100,000 | 137,600,000 | · | · | · | · | · | |
| EBITDA | $-20M | · | $-16M | $-21M | $-18M | · | $-12M | $-15M | $-13M | · | $-12M | $-13M |
Bilans 20
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $55M | $31M | $46M | $23M | $41M | $43M | $37M | $19M | $24M | $24M | $30M | $19M | |
| Short-term Investments | $140M | $178M | $174M | $78M | $72M | $83M | $99M | $127M | $133M | $128M | $133M | $149M | |
| Prepaid Expense | $1M | $913.0K | $1M | $5M | $12M | $6M | $6M | $7M | $2M | $1M | $3M | $7M | |
| Current Assets | $196M | $210M | $221M | $106M | $124M | $133M | $141M | $154M | $159M | $154M | $167M | $175M | |
| PP&E (Net) | $169.0K | $102.0K | $119.0K | $131.0K | $231.0K | $353.0K | $493.0K | $592.0K | $744.0K | $898.0K | $1M | $1M | |
| PP&E (Gross) | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | · | · | · | · | · | · | $568.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | |
| Total Assets | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Accounts Payable | $906.0K | $2M | $3M | $3M | $2M | $2M | $960.0K | $1M | $854.0K | $4M | $2M | $724.0K | |
| Accrued Liabilities | $8M | $11M | $9M | $11M | $13M | $6M | $3M | $7M | $2M | $3M | $6M | $8M | |
| Current Liabilities | $10M | $14M | $12M | $14M | $15M | $9M | $4M | $10M | $4M | $8M | $9M | $10M | |
| Capital Leases | $8M | $9M | $9M | $10M | $6M | $6M | $6M | $0 | $189.0K | $536.0K | $869.0K | $1M | |
| Total Liabilities | $19M | $23M | $22M | $23M | $21M | $15M | $11M | $10M | $4M | $8M | $10M | $11M | |
| Common Stock | $18.0K | $18.0K | $53.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | |
| Retained Earnings | $-449M | $-431M | $-415M | $-401M | $-381M | $-365M | $-350M | $-339M | $-326M | $-315M | $-302M | $-292M | |
| AOCI | $-159.0K | $280.0K | $274.0K | $208.0K | $190.0K | $210.0K | $486.0K | $-91.0K | $-90.0K | $37.0K | $-430.0K | $-507.0K | |
| Stockholders' Equity | $186M | $197M | $210M | $93M | $110M | $125M | $138M | $146M | $157M | $149M | $160M | $168M | |
| Liabilities + Equity | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Shares Outstanding | 180,088,000 | 178,324,000 | 177,572,000 | 138,282,000 | 138,282,000 | 137,820,000 | 137,589,000 | 137,589,000 | 137,589,000 | 127,668,000 | 127,445,000 | 127,388,000 |
Przepływy pieniężne 10
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15.0K | $17.0K | $19.0K | $100.0K | $140.0K | $140.0K | $143.0K | $152.0K | $154.0K | $161.0K | $164.0K | $180.0K | |
| Stock-based Comp | $5M | $2M | $1M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-17M | $-13M | $-11M | $-12M | $-13M | $-9M | $-11M | $-11M | $-14M | $-12M | $-6M | $-10M | |
| CapEx | $82.0K | $0 | $7.0K | $0 | $18.0K | $0 | $44.0K | $0 | $0 | $9.0K | $10.0K | $11.0K | |
| Investing Cash Flow | $38M | $-3M | $-95M | $-6M | $12M | $15M | $29M | $6M | $-4M | $6M | $17M | $-667.0K | |
| Stock Issued | · | $0 | $138M | $0 | $0 | $0 | $0 | $0 | $18M | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | $0 | · | · | · | $18M | · | · | · | |
| Financing Cash Flow | $3M | $1M | $129M | $0 | $-815.0K | $-94.0K | $-2.0K | $1.0K | $17M | $-158.0K | $21.0K | $3M | |
| Net Change in Cash | $25M | $-16M | $23M | $-18M | $-2M | $6M | $18M | $-4M | $-554.0K | $-6M | $11M | $-8M | |
| Free Cash Flow | $-17M | · | · | · | $-13M | · | · | · | · | · | · | · |
Rentowność 7
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| ROA | -10.9% | · | -7.5% | -14.6% | -11.4% | · | -6.6% | -7.8% | -6.2% | · | -6.7% | -7.1% | |
| ROE | -12.3% | · | -8.2% | -16.6% | -12.4% | · | -7.0% | -8.3% | -6.5% | · | -7.2% | -7.6% | |
| ROIC | · | · | · | · | -16.3% | · | · | -10.3% | -8.1% | · | -7.4% | -7.9% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.0 | · | 17.8 | 7.7 | 8.3 | · | 31.8 | 16.2 | 40.7 | · | 18.3 | 18.1 | |
| Quick Ratio | 18.9 | · | 17.7 | 7.3 | 7.6 | · | 30.5 | 15.4 | 40.1 | · | 17.9 | 17.4 |
Efektywność 1
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | · | · |
Wycena (TTM) 6
| Wskaźnik | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-69M | · | $-61M | $-60M | $-51M | · | $-44M | $-45M | $-40M | · | $-41M | $-40M | |
| Market Cap | $953M | · | $622M | $360M | $263M | · | $253M | $138M | $272M | · | $251M | $405M | |
| P/B | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Tangible Book | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Cash Flow | -55.2 | · | · | · | -19.9 | · | · | · | -19.6 | · | · | · | |
| P / FCF | -54.9 | · | · | · | -19.9 | · | · | · | · | · | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $0 | $850.0K | $0 | — | — |
| Marża Operacyjna % | — | -6661.8% | — | — | — |
| Zysk netto | $-66M | $-49M | $-42M | $-39M | $-82M |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | — | — | 0.0 |
| Wskaźnik bieżący | 15.0 | 15.0 | 19.7 | 12.0 | 13.8 |
| Wskaźnik Szybkości | 15.0 | 14.3 | 19.5 | 11.5 | 13.6 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-49M | $-45M | $-41M | $-34M | $-21M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.